Skip to main content

Table 2 Patient characteristics (N = 211)

From: Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxel-based chemotherapy in breast cancer patients

  Mean ± SD N (%)
Age at diagnosis (years) 54.278 ± 10.163  
Menopausal state
 premenopausal   63 (29.9)
 postmenopausal   148 (70.1)
Age at postmenopause (years) 52.367 ± 8.132  
Height (cm) 159.672 ± 5.369  
Weight (kg) 62.483 ± 8.859  
BMI (kg.m−2) 24.114 ± 3.156  
Parity   194 (91.9)
  1. BMI body mass index